Our Blog

June 20, 2017
Medical Cannabis and ALS

Medical Cannabis and ALS

Amyotrophic Lateral Sclerosis (ALS) is a neuromuscular disorder caused by the gradual degeneration of the motor nerve cells.

June 5, 2017

The Makings of a Cannabis Titan

Aphria cultivates low-cost medical cannabis in Canada’s high-tech greenhouse capital.

May 19, 2017

‘Taking Short Cuts Will Catch Up To You In The End’: Aphria CEO Vic Neufeld On His Success In The Cannabis Industry

After two decades in the pharmaceutical industry, Vic Neufeld talks about his success in the Cannabis Industry.

May 1, 2017

5 Most Common Questions Every Parent Asks When Considering Medical Cannabis for their Children

Parents are turning to medical cannabis, typically in the form of oil, as a critical means of improving the health of their children.

April 21, 2017

Podcast: Difference between Dried Cannabis and Cannabis Oil

From consumption methods to onset effects, today's podcast offers a great overview of what you need to know when consuming dried cannabis and cannabis oil.

April 11, 2017

Medical Marijuana and Parkinson’s Disease

Parkinson's disease is a chronic degenerative disorder of the central nervous system that affects nerve cells in the brain and makes movement difficult.

April 6, 2017

Actual vs. Potential Values on Product Labels

Licensed Producers are now required to report both actual and potential potencies on product labels.

April 2, 2017

Cannabis Oil and Autism

Autism spectrum disorder (autism) is a complex neurobiological condition that can affect the normal function...

March 30, 2017

3 Frequently Asked Patient Questions of the Month

Introducing Aphria's frequently asked questions post. This month our top 3 questions are focused around prescriptions and travel.